Common side effects include low blood sugar, problems at the site of injection, itchiness, and weight gain. Serious side effects include low blood potassium. As of 2012, tentative evidence shows no association between<unk>  and cancer. Previous studies had raised concerns. When comparing<unk>  to NPH insulin, insulin detemir or insulin degludec, no significant adverse effects were found in the management of type I Diabetes in neither adults or children in periods of 6 months or longer.
Insulin glargine
Insulin aspart
Insulin glulisine
Lente insulin
Regular insulin
Insulin detemir
NPH insulin
Insulin lispro